Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to new medicines among people living with progressive forms of MS.

The National Institute for Health and Care Excellence (NICE) appraises all new medicines, including for multiple sclerosis, and is committed where possible, to publishing draft guidance at the time of licensing with final guidance published within three months. NICE has published guidance recommending a number of medicines for multiple sclerosis for routine use in the National Health Service. The NHS in England is legally required to fund medicines recommended by NICE.